LexDanaLexDanabeta
Inventor

Ronald Charles Hawley

Inventor
Mountain View, CA, US

Overview

55→
Patents
1995–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 55 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07HSugars2%
C07JSteroids2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
B29CShaping or joining of plastics1%
B29DProducing particular articles from plastics or from substances in a plastic state1%
PatentTitleYear
11,104,097Composite structural article202111,001,412Composite pallet202110,822,311Pyrimidines and variants thereof, and uses therefor202010,676,444Crystalline salts and polymorphs of a P2X3 antagonist202010,662,162Pyrimidines and variants thereof, and uses therefor202010,201,525Tetrazole-substituted arylamides as PX20199,896,439'Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20189,849,136Thiazole and oxazole-substituted arylamides as P2X20179,617,254'Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20179,593,128'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20179,556,127'Diaminopyrimidines as P2X3 and P2X2/3 antagonists'20179,512,089'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20169,505,726'Substituted biphenyl amides as P2X3 and P2X2/3 antagonists'20169,505,758'Substituted 1,5-naphthyridines as endonuclease inhibitors'20169,199,987'Substituted naphthyridines for the treatment, amelioration or prevention of a viral disease'20159,045,486'Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease'20158,952,039'Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral disease'20158,895,589'Pyridinyl amides as P2X3 and P2X2/3 inhibitors'20148,846,705'Diaminopyrimidines as P2X3 and P2X2/3 antagonists'20148,846,945'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20148,841,336'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20148,524,725'Methods of using diaminopyrimidine as P2X3 and P2Xâ…” receptor modulators for treatment of respiratory and gastrointestinal diseases'20138,501,933'Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20138,440,708'Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20138,440,673'Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20138,318,719'Inhibitors of Bruton\'s tyrosine kinase'20128,283,383'Biphenyl amides as P2X3 and P2X2/3 antagonists'20128,193,368'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20128,048,905'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20118,008,313'Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases'20117,989,637'Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20117,858,654'Imidazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20107,858,632'Diaminopyrimidines as P2X3 and P2X2/3 antagonists'20107,786,110'Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20107,595,405'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists'20097,476,727'Conjugates of mycophenolic acid'20097,285,561'Imidazo-substituted compounds as p38 kinase inhibitors'20077,285,559'Imidazo-substituted compounds as p38 kinase inhibitors'20077,235,675'Conjugates of mycophenolic acid'20077,186,841'Antiinflammation agents'20077,157,580'Aminopyrimidine and aminopyridine anti-inflammation agents'20077,081,462'Imidazo-substituted compounds as p38 kinase inhibitors'20066,949,560'Imidazo-substituted compounds as p38 kinase inhibitors'20056,846,828'Aminopyrimidine and aminopyridine anti-inflammation agents'20056,846,834'Antiinflammation agents'20056,811,998'Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase'20046,524,808'Enzyme inhibition immunoassay'20035,633,279'5-substituted derivatives of mycophenolic acid'19975,554,612'4-amino 6-substitutes mycophenolic acid and derivatives'19965,538,969'4-amino derivatives of 5-substituted mycophenolic acid'19965,536,747'6-substituted mycophenolic acid and derivatives'19965,525,602'Method of using 4-amino 6-substituted mycophenolic acid and derivatives'19965,512,568'Method of using 4-amino derivatives of 5-substituted mycophenolic acid'19965,493,030'5-substituted derivatives of mycophenolic acid'19965,444,072'6-substituted mycophenolic acid and derivatives'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–1997Patents assigned to SYNTEX INC (8)· patent assignee history
1995–1997Based in Woodside, CA, US· patent location history
2003–2019Based in Mountain View, CA, US· patent location history
2005–2019Patents assigned to ROCHE PALO ALTO LLC (30)· patent assignee history
2012–2017Patents assigned to HAWLEY RONALD CHARLES (12)· patent assignee history
2012–2017Patents assigned to DILLON MICHAEL PATRICK (9)· patent assignee history
2012–2017Patents assigned to CHEN LI (7)· patent assignee history
2012–2016Based in Glen Ridge, NJ, US· patent location history
2015Based in San Francisco, CA, US· patent location history
2016–2020Based in Oakland, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ROCHE PALO ALTO LLC302005–2019
HAWLEY RONALD CHARLESself122012–2017
DILLON MICHAEL PATRICK92012–2017
SYNTEX INC81995–1997
CHEN LI72012–2017
Locations
LocationPatentsSpan
Mountain View, California, US342003–2019
Woodside, California, US71995–1997
Glen Ridge, New Jersey, US42012–2016
Oakland, California, US32016–2020
San Francisco, California, US32015